Supreme Board Of Drug: A Huge Efforts By Producers And The Political Council Towards Self-Sufficiency

Head of the Supreme Board of Drug and Medical Device Mohammed Al-Madani confirmed that there is a great trend by producers and the political council in Sana’a towards self-sufficiency in accordance with the national strategy for the manufacture of medicines issued in 2018.

In a statement, Al-Madani to Almasirah on Saturday that 2019 witnessed a qualitative development and a big boom in the local industries. The percentage of its contribution in the production of medicines and providing them to the local market exceeded 20% , while it was before the aggression 10%.

“We hope the local pharmaceutical industries will exceed 30% of production this year,” he added.

For his part, the Head of the Drug Storage Division indicated that in 2017 a project was added to add 100 scientific names from the important names mentioned in the main list to be added as new varieties in the local industry.

He stressed that there can be no drug security without local industries as it is one of the most important tributaries of the country’s drug stock.

Regarding the corona pandemic, the Head of the Drug Storage Division said, “We launched a list of 20 classes of medicines and directed local factories to the necessity of speeding their manufacture. A significant quantities of them were produced .”

For his part, Head of the Federation of Pharmaceutical Producers Dr. Hussein Al-Rabahi said that the pharmaceutical industry has made great progress in providing medicine to the Yemeni citizen and has gained over the past 23 years a role in providing essential and life-saving medicines.

“Pharmaceutical industries in Yemen are now considered essential and modern in their scientific and technological concept, because they rely on great scientific competencies, advanced equipment, qualified personnel and trained at a high level”, he added.

He went on saying, “We are seeking, through the manufacture of pharmaceutical items, to be self-sufficient, especially in essential medicines, and therefore there will be no need for import.”

He pointed out that when local pharmaceutical industries improve in the future, it is possible to start finding and manufacturing raw materials for these important industries.